Tokyo Tape
Sign in
← Ain Holdings

Quarterly report · Q3

9627.TEDINET S100T2A7
Period2023-05-01 → 2024-01-31
Filed2024-03-15
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 33
MetricValuePeriodScopeSource row
Revenue¥296.4bn2023-05-01 → 2024-01-31Cons.Net sales
Revenue¥358.7bn2022-05-01 → 2023-04-30Cons.Net sales (5-year summary)
Revenue¥263.9bn2022-05-01 → 2023-01-31Cons.Net sales
Operating income¥14.3bn2023-05-01 → 2024-01-31Cons.Operating income
Operating income¥11.7bn2022-05-01 → 2023-01-31Cons.Operating income
Ordinary income¥15.1bn2023-05-01 → 2024-01-31Cons.Ordinary income
Ordinary income¥17.1bn2022-05-01 → 2023-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥12.4bn2022-05-01 → 2023-01-31Cons.Ordinary income
Profit before tax¥15.0bn2023-05-01 → 2024-01-31Cons.Income before income taxes
Profit before tax¥12.1bn2022-05-01 → 2023-01-31Cons.Income before income taxes
Net income (owners)¥8.7bn2023-05-01 → 2024-01-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥9.2bn2022-05-01 → 2023-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥6.6bn2022-05-01 → 2023-01-31Cons.Profit loss attributable to owners of parent
Net income¥8.7bn2023-05-01 → 2024-01-31Cons.Profit loss
Net income¥6.6bn2022-05-01 → 2023-01-31Cons.Profit loss
Total assets¥243.7bnat 2024-01-31Cons.Assets
Total assets¥231.8bnat 2023-04-30Cons.Assets
Total assets¥229.6bnat 2023-01-31Cons.Total assets (5-year summary)
Total liabilities¥110.4bnat 2024-01-31Cons.Liabilities
Total liabilities¥105.2bnat 2023-04-30Cons.Liabilities
Net assets / equity¥133.3bnat 2024-01-31Cons.Net assets
Net assets / equity¥126.5bnat 2023-04-30Cons.Net assets
Net assets / equity¥123.7bnat 2023-01-31Cons.Net assets (5-year summary)
Cash and deposits¥50.1bnat 2024-01-31Cons.Cash and deposits
Cash and deposits¥46.8bnat 2023-04-30Cons.Cash and deposits
EPS (basic)¥248.512023-05-01 → 2024-01-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥98.852023-11-01 → 2024-01-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥262.872022-05-01 → 2023-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥188.72022-05-01 → 2023-01-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥80.42022-11-01 → 2023-01-31dCons.Basic earnings loss per share (5-year summary)
Equity ratio54.7%at 2024-01-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.6%at 2023-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio53.9%at 2023-01-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2023-05-01 → 2024-01-31¥8.5bn
Otherother segmentsrevenue external2023-05-01 → 2024-01-31¥8.4bn
Otherother segmentsrevenue intersegment2023-05-01 → 2024-01-31¥37m
Otherother segmentssegment ordinary income2023-05-01 → 2024-01-31−¥80m
Reconciling Itemsreconcilingrevenue2023-05-01 → 2024-01-31−¥37m
Reconciling Itemsreconcilingrevenue intersegment2023-05-01 → 2024-01-31−¥37m
Reconciling Itemsreconcilingsegment ordinary income2023-05-01 → 2024-01-31−¥6.8bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentrevenue2023-05-01 → 2024-01-31¥265.0bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2023-05-01 → 2024-01-31¥265.0bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2023-05-01 → 2024-01-31¥19.7bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2023-05-01 → 2024-01-31¥22.9bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2023-05-01 → 2024-01-31¥22.9bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2023-05-01 → 2024-01-31¥2.2bn
—segment totalrevenue2023-05-01 → 2024-01-31¥296.4bn
—segment totalrevenue external2023-05-01 → 2024-01-31¥296.4bn
—segment totalrevenue intersegment2023-05-01 → 2024-01-31¥37m
—segment totalsegment ordinary income2023-05-01 → 2024-01-31¥21.9bn
Otherother segmentsrevenue2022-05-01 → 2023-01-31¥8.7bn
Otherother segmentsrevenue external2022-05-01 → 2023-01-31¥8.7bn
Otherother segmentsrevenue intersegment2022-05-01 → 2023-01-31¥43m
Otherother segmentssegment ordinary income2022-05-01 → 2023-01-31−¥2m
Reconciling Itemsreconcilingrevenue2022-05-01 → 2023-01-31−¥43m
Reconciling Itemsreconcilingrevenue intersegment2022-05-01 → 2023-01-31−¥43m
Reconciling Itemsreconcilingsegment ordinary income2022-05-01 → 2023-01-31−¥6.4bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentrevenue2022-05-01 → 2023-01-31¥236.4bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2022-05-01 → 2023-01-31¥236.4bn
jpcrp040300-q3r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2022-05-01 → 2023-01-31¥18.0bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2022-05-01 → 2023-01-31¥18.8bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2022-05-01 → 2023-01-31¥18.8bn
jpcrp040300-q3r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2022-05-01 → 2023-01-31¥737m
—segment totalrevenue2022-05-01 → 2023-01-31¥263.9bn
—segment totalrevenue external2022-05-01 → 2023-01-31¥263.9bn
—segment totalrevenue intersegment2022-05-01 → 2023-01-31¥43m
—segment totalsegment ordinary income2022-05-01 → 2023-01-31¥18.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 375
ItemContextValueUnit
Other eiPrior1YTDDuration1000000JPY
Other eiCurrentYTDDuration4000000JPY
Extraordinary incomePrior1YTDDuration113000000JPY
Extraordinary incomeCurrentYTDDuration439000000JPY
Loss on sales and retirement of noncurrent assets elPrior1YTDDuration153000000JPY
Loss on sales and retirement of noncurrent assets elCurrentYTDDuration133000000JPY
Impairment loss elPrior1YTDDuration183000000JPY
Impairment loss elCurrentYTDDuration219000000JPY
Other elPrior1YTDDuration36000000JPY
Other elCurrentYTDDuration106000000JPY
Extraordinary lossPrior1YTDDuration372000000JPY
Extraordinary lossCurrentYTDDuration459000000JPY
Income before income taxesPrior1YTDDuration12108000000JPY
Income before income taxesCurrentYTDDuration15031000000JPY
Income taxesPrior1YTDDuration5497000000JPY
Income taxesCurrentYTDDuration6325000000JPY
Profit lossPrior1YTDDuration6611000000JPY
Profit lossCurrentYTDDuration8705000000JPY
Profit loss attributable to non controlling interestsPrior1YTDDuration-17000000JPY
Profit loss attributable to non controlling interestsCurrentYTDDuration-24000000JPY
Profit loss attributable to owners of parentPrior1YTDDuration6628000000JPY
Profit loss attributable to owners of parentCurrentYTDDuration8730000000JPY
Profit lossPrior1YTDDuration6611000000JPY
Profit lossCurrentYTDDuration8705000000JPY
Valuation difference on available for sale securities net of tax ociPrior1YTDDuration14000000JPY
Valuation difference on available for sale securities net of tax ociCurrentYTDDuration145000000JPY
Remeasurements of defined benefit plans net of tax ociPrior1YTDDuration18000000JPY
Remeasurements of defined benefit plans net of tax ociCurrentYTDDuration-22000000JPY
Other comprehensive incomePrior1YTDDuration32000000JPY
Other comprehensive incomeCurrentYTDDuration122000000JPY
Comprehensive incomePrior1YTDDuration6643000000JPY
Comprehensive incomeCurrentYTDDuration8828000000JPY
Comprehensive income attributable to owners of the parentPrior1YTDDuration6661000000JPY
Comprehensive income attributable to owners of the parentCurrentYTDDuration8852000000JPY
Comprehensive income attributable to non controlling interestsPrior1YTDDuration-17000000JPY
Comprehensive income attributable to non controlling interestsCurrentYTDDuration-24000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E04896-000DispensingPharmacyReportableSegmentsMember236396000000JPY
Revenues from external customersPrior1YTDDuration_jpcrp040300-q3r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember18836000000JPY
Revenues from external customersPrior1YTDDuration_OtherReportableSegmentsMember8672000000JPY
Revenues from external customersPrior1YTDDuration_ReportableSegmentsMember263906000000JPY
Revenues from external customersPrior1YTDDuration_ReconcilingItemsMember－JPY
Revenues from external customersPrior1YTDDuration263906000000JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E04896-000DispensingPharmacyReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_jpcrp040300-q3r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember－JPY
Transactions with other segmentsPrior1YTDDuration_OtherReportableSegmentsMember43000000JPY
Transactions with other segmentsPrior1YTDDuration_ReportableSegmentsMember43000000JPY
Transactions with other segmentsPrior1YTDDuration_ReconcilingItemsMember-43000000JPY
Transactions with other segmentsPrior1YTDDuration－JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E04896-000DispensingPharmacyReportableSegmentsMember236396000000JPY
Net salesPrior1YTDDuration_jpcrp040300-q3r_E04896-000DrugAndCosmeticStoreReportableSegmentsMember18836000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-04-30pass
balance sheet identityconsolidated 2024-01-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-04-30pass
statement vs summary · net assetsconsolidated 2024-01-31pass
statement vs summary · net income attributable to parentconsolidated 2022-05-01/2023-01-31pass
statement vs summary · net income attributable to parentconsolidated 2023-05-01/2024-01-31pass
statement vs summary · revenueconsolidated 2022-05-01/2023-01-31pass
statement vs summary · revenueconsolidated 2023-05-01/2024-01-31pass
statement vs summary · total assetsconsolidated 2023-04-30pass
statement vs summary · total assetsconsolidated 2024-01-31pass